3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine

C167H133F7N48O12S3 — CID 158292614

IUPAC3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine
SMILESC.CCc1ccccc1CNC(=O)c1nc2ccccc2nc1N.CS(=O)(=O)Nc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Cc1cccc(-c2nnc(-c3nc4ccccc4nc3N)o2)c1.Nc1nc2cc(F)c(F)cc2nc1C(=O)NCc1ccccc1C(F)(F)F.Nc1nc2ccccc2nc1-c1nnc(-c2c(F)cccc2F)o1.Nc1nc2ccccc2nc1-c1nnc(-c2cccs2)o1.Nc1nc2ccccc2nc1-c1noc(Cc2ccccc2)n1.Nc1nc2ccccc2nc1C(=O)NCc1ccccc1-c1ccccc1.Nc1nc2ccccc2nc1C(=O)NCc1ccccn1.Nc1nc2ccccc2nc1C(=O)NCc1nccs1
InChIInChI=1S/C22H18N4O.C18H18N4O.C17H11F5N4O.C17H14N6O3S.2C17H13N5O.C16H9F2N5O.C15H13N5O.C14H9N5OS.C13H11N5OS.CH4/c23-21-20(25-18-12-6-7-13-19(18)26-21)22(27)24-14-16-10-4-5-11-17(16)15-8-2-1-3-9-15;1-2-12-7-3-4-8-13(12)11-20-18(23)16-17(19)22-15-10-6-5-9-14(15)21-16;18-10-5-12-13(6-11(10)19)26-15(23)14(25-12)16(27)24-7-8-3-1-2-4-9(8)17(20,21)22;1-27(24,25)23-11-7-3-2-6-10(11)16-21-22-17(26-16)14-15(18)20-13-9-5-4-8-12(13)19-14;1-10-5-4-6-11(9-10)16-21-22-17(23-16)14-15(18)20-13-8-3-2-7-12(13)19-14;18-16-15(19-12-8-4-5-9-13(12)20-16)17-21-14(23-22-17)10-11-6-2-1-3-7-11;17-8-4-3-5-9(18)12(8)15-22-23-16(24-15)13-14(19)21-11-7-2-1-6-10(11)20-13;16-14-13(19-11-6-1-2-7-12(11)20-14)15(21)18-9-10-5-3-4-8-17-10;15-12-11(16-8-4-1-2-5-9(8)17-12)14-19-18-13(20-14)10-6-3-7-21-10;14-12-11(13(19)16-7-10-15-5-6-20-10)17-8-3-1-2-4-9(8)18-12;/h1-13H,14H2,(H2,23,26)(H,24,27);3-10H,2,11H2,1H3,(H2,19,22)(H,20,23);1-6H,7H2,(H2,23,26)(H,24,27);2-9,23H,1H3,(H2,18,20);2-9H,1H3,(H2,18,20);1-9H,10H2,(H2,18,20);1-7H,(H2,19,21);1-8H,9H2,(H2,16,20)(H,18,21);1-7H,(H2,15,17);1-6H,7H2,(H2,14,18)(H,16,19);1H4
InChIKeyGLNSNYWLMZPACZ-UHFFFAOYSA-N
MW3233.41 g/mol
LogP28.31
Rot. Bonds30

About 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine

3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine (PubChem CID 158292614) has the molecular formula C167H133F7N48O12S3 and a molecular weight of 3233.41 g/mol. Its IUPAC name is 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine.

Molecular Properties

Compound Name3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine
PubChem CID158292614
Molecular FormulaC167H133F7N48O12S3
Molecular Weight3233.41 g/mol
Exact Mass3231.03
IUPAC Name3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine
SMILESC.CCc1ccccc1CNC(=O)c1nc2ccccc2nc1N.CS(=O)(=O)Nc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Cc1cccc(-c2nnc(-c3nc4ccccc4nc3N)o2)c1.Nc1nc2cc(F)c(F)cc2nc1C(=O)NCc1ccccc1C(F)(F)F.Nc1nc2ccccc2nc1-c1nnc(-c2c(F)cccc2F)o1.Nc1nc2ccccc2nc1-c1nnc(-c2cccs2)o1.Nc1nc2ccccc2nc1-c1noc(Cc2ccccc2)n1.Nc1nc2ccccc2nc1C(=O)NCc1ccccc1-c1ccccc1.Nc1nc2ccccc2nc1C(=O)NCc1ccccn1.Nc1nc2ccccc2nc1C(=O)NCc1nccs1
InChIInChI=1S/C22H18N4O.C18H18N4O.C17H11F5N4O.C17H14N6O3S.2C17H13N5O.C16H9F2N5O.C15H13N5O.C14H9N5OS.C13H11N5OS.CH4/c23-21-20(25-18-12-6-7-13-19(18)26-21)22(27)24-14-16-10-4-5-11-17(16)15-8-2-1-3-9-15;1-2-12-7-3-4-8-13(12)11-20-18(23)16-17(19)22-15-10-6-5-9-14(15)21-16;18-10-5-12-13(6-11(10)19)26-15(23)14(25-12)16(27)24-7-8-3-1-2-4-9(8)17(20,21)22;1-27(24,25)23-11-7-3-2-6-10(11)16-21-22-17(26-16)14-15(18)20-13-9-5-4-8-12(13)19-14;1-10-5-4-6-11(9-10)16-21-22-17(23-16)14-15(18)20-13-8-3-2-7-12(13)19-14;18-16-15(19-12-8-4-5-9-13(12)20-16)17-21-14(23-22-17)10-11-6-2-1-3-7-11;17-8-4-3-5-9(18)12(8)15-22-23-16(24-15)13-14(19)21-11-7-2-1-6-10(11)20-13;16-14-13(19-11-6-1-2-7-12(11)20-14)15(21)18-9-10-5-3-4-8-17-10;15-12-11(16-8-4-1-2-5-9(8)17-12)14-19-18-13(20-14)10-6-3-7-21-10;14-12-11(13(19)16-7-10-15-5-6-20-10)17-8-3-1-2-4-9(8)18-12;/h1-13H,14H2,(H2,23,26)(H,24,27);3-10H,2,11H2,1H3,(H2,19,22)(H,20,23);1-6H,7H2,(H2,23,26)(H,24,27);2-9,23H,1H3,(H2,18,20);2-9H,1H3,(H2,18,20);1-9H,10H2,(H2,18,20);1-7H,(H2,19,21);1-8H,9H2,(H2,16,20)(H,18,21);1-7H,(H2,15,17);1-6H,7H2,(H2,14,18)(H,16,19);1H4
InChIKeyGLNSNYWLMZPACZ-UHFFFAOYSA-N
XLogP28.31
TPSA930.05 Ų
H-Bond Donors16
H-Bond Acceptors56
Rotatable Bonds30
Heavy Atoms237
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003233.41
LogP ≤ 528.31
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1056

Analyze 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[5-(1-aminoisoquinolin-4-yl)-2-pyridinyl]-N'-hydroxybenzenecarboximidamide;4-[3-(8-amino-1,7-naphthyridin-5-yl)-1,2,4-oxadiazol-5-yl]-N'-hydroxybenzenecarboximidamide;4-[5-(8-amino-1,7-naphthyridin-5-yl)-1,3,4-oxadiazol-2-yl]-N'-hydroxybenzenecarboximidamide;4-[5-(8-amino-1,7-naphthyridin-5-yl)-1,3-oxazol-2-yl]-N'-hydroxybenzenecarboximidamide;4-[2-(8-amino-1,7-naphthyridin-5-yl)-1,3-thiazol-4-yl]-N'-hydroxybenzenecarboximidamide;4-[1-(2-aminoquinolin-4-yl)pyrazol-3-yl]-N'-hydroxybenzenecarboximidamide
CID 158022304
N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-(5-benzyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;tris(1,6-diethylcyclohexene);3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(1,2-dimethylcyclohexa-1,3-diene);1,2-dimethylcyclohexane;1,2-dimethylcyclohexene;3,4-dimethylcyclohexene;2,3-dimethylpentane;2,3-dimethylpent-1-ene;ethylcyclohexane;1-ethylcyclohexene;4-ethyl-5-methylcyclohexene;1-fluoro-3,4,6-trimethylcyclohexene;3-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine;2,3,4-trimethylpenta-1,4-diene;2,3,4-trimethylpent-1-ene
CID 158046554

Frequently Asked Questions

What is the IUPAC name of 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine?
The IUPAC name of 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine (CID 158292614) is 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine.
What is the SMILES notation for 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine?
The canonical SMILES for 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine is C.CCc1ccccc1CNC(=O)c1nc2ccccc2nc1N.CS(=O)(=O)Nc1ccccc1-c1nnc(-c2nc3ccccc3nc2N)o1.Cc1cccc(-c2nnc(-c3nc4ccccc4nc3N)o2)c1.Nc1nc2cc(F)c(F)cc2nc1C(=O)NCc1ccccc1C(F)(F)F.Nc1nc2ccccc2nc1-c1nnc(-c2c(F)cccc2F)o1.Nc1nc2ccccc2nc1-c1nnc(-c2cccs2)o1.Nc1nc2ccccc2nc1-c1noc(Cc2ccccc2)n1.Nc1nc2ccccc2nc1C(=O)NCc1ccccc1-c1ccccc1.Nc1nc2ccccc2nc1C(=O)NCc1ccccn1.Nc1nc2ccccc2nc1C(=O)NCc1nccs1.
What is the InChIKey of 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine?
The InChIKey is GLNSNYWLMZPACZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H18N4O.C18H18N4O.C17H11F5N4O.C17H14N6O3S.2C17H13N5O.C16H9F2N5O.C15H13N5O.C14H9N5OS.C13H11N5OS.CH4/c23-21-20(25-18-12-6-7-13-19(18)26-21)22(27)24-14-16-10-4-5-11-17(16)15-8-2-1-3-9-15;1-2-12-7-3-4-8-13(12)11-20-18(23)16-17(19)22-15-10-6-5-9-14(15)21-16;18-10-5-12-13(6-11(10)19)26-15(23)14(25-12)16(27)24-7-8-3-1-2-4-9(8)17(20,21)22;1-27(24,25)23-11-7-3-2-6-10(11)16-21-22-17(26-16)14-15(18)20-13-9-5-4-8-12(13)19-14;1-10-5-4-6-11(9-10)16-21-22-17(23-16)14-15(18)20-13-8-3-2-7-12(13)19-14;18-16-15(19-12-8-4-5-9-13(12)20-16)17-21-14(23-22-17)10-11-6-2-1-3-7-11;17-8-4-3-5-9(18)12(8)15-22-23-16(24-15)13-14(19)21-11-7-2-1-6-10(11)20-13;16-14-13(19-11-6-1-2-7-12(11)20-14)15(21)18-9-10-5-3-4-8-17-10;15-12-11(16-8-4-1-2-5-9(8)17-12)14-19-18-13(20-14)10-6-3-7-21-10;14-12-11(13(19)16-7-10-15-5-6-20-10)17-8-3-1-2-4-9(8)18-12;/h1-13H,14H2,(H2,23,26)(H,24,27);3-10H,2,11H2,1H3,(H2,19,22)(H,20,23);1-6H,7H2,(H2,23,26)(H,24,27);2-9,23H,1H3,(H2,18,20);2-9H,1H3,(H2,18,20);1-9H,10H2,(H2,18,20);1-7H,(H2,19,21);1-8H,9H2,(H2,16,20)(H,18,21);1-7H,(H2,15,17);1-6H,7H2,(H2,14,18)(H,16,19);1H4.
What are the key properties of 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine?
3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine has a molecular weight of 3233.41 g/mol, XLogP of 28.31, 30 rotatable bonds, 16 hydrogen bond donors, and 56 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-6,7-difluoro-N-[[2-(trifluoromethyl)phenyl]methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-ethylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-[(2-phenylphenyl)methyl]quinoxaline-2-carboxamide;3-amino-N-(pyridin-2-ylmethyl)quinoxaline-2-carboxamide;N-[2-[5-(3-aminoquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methanesulfonamide;3-amino-N-(1,3-thiazol-2-ylmethyl)quinoxaline-2-carboxamide;3-(5-benzyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-[5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;methane;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine is sourced from PubChem (CID 158292614), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).